BHI News Section Archives - Page 3 of 1201

News

March 5, 2025

REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases

ROCKVILLE, Md., March 4, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the closing of its previously announced strategic partnership with Nippon Shinyaku. Under…

Andy

Love0

News

March 5, 2025

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection

POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced an advancement…

Andy

Love0

News

March 4, 2025

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication expansion…

Andy

Love0

News

March 3, 2025

Venture Valkyrie: Tough Love for Women’s Health Entrepreneurs Raising Venture Money

Since I have been raising and deploying a venture fund focused on addressing health of women lately, I have had numerous occasions…

Andy

Love0

News

March 3, 2025

BioBuzz: TEDCO’s Impact on Maryland’s Entrepreneurial Ecosystem

By Annabel Baldy - In November’s What’s the Buzz?! LinkedIn Live session, Chris Frew, CEO of BioBuzz and Tammi Thomas, Chief Development…

Andy

Love0

News

March 3, 2025

GEN: Former NIH Director Francis Collins Praises the Institution as He Abruptly Departs After Three Decades

By Kevin Davies, PhD - March 3, 2025 - After an illustrious career including 12 years as director of the…

Andy

Love0

News

February 28, 2025

GEN: FDA Accepts for Review Precigen RRP Gene Therapy Candidate

By Alex Philippidis - February 26, 2025 - The FDA has granted Priority Review to Precigen’s Biologics License Application (BLA)…

Andy

Love0

News

February 26, 2025

TNF Pharmaceuticals Launches Phase 2b Trial for First Oral TNF-Alpha Inhibitor to Combat Muscle Loss and Frailty

BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies…

Andy

Love0

News

February 26, 2025

CityBiz – Protenus: From Accelerator to Acquisition

Protenus, a leading healthcare compliance analytics platform that serves over 200 healthcare organizations, was acquired in January 2025 by Bluesight, a prominent provider…

Andy

Love0

News

February 25, 2025

TEDCO Announces Investment in Pathotrak

COLUMBIA, Md., (February 25, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $250,000 Venture Funds investment…

Andy

Love0

BHI News Section

REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

Venture Valkyrie: Tough Love for Women’s Health Entrepreneurs Raising Venture Money

BioBuzz: TEDCO’s Impact on Maryland’s Entrepreneurial Ecosystem

GEN: Former NIH Director Francis Collins Praises the Institution as He Abruptly Departs After Three Decades

GEN: FDA Accepts for Review Precigen RRP Gene Therapy Candidate

TNF Pharmaceuticals Launches Phase 2b Trial for First Oral TNF-Alpha Inhibitor to Combat Muscle Loss and Frailty

CityBiz – Protenus: From Accelerator to Acquisition

TEDCO Announces Investment in Pathotrak

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search